Neuro-Oncology
Reviews


Volume 24 Number 13
15 July 2022


Home > Publications > Neuro-Oncology Reviews > Volume 24, Year 2022 > Number 13, 15 July






Salari N, Fatahian R, Kazeminia M, Hosseinian-Far A, Shohaimi S, Mohammadi M.
Patients' Survival with Astrocytoma After Treatment: a Systematic Review and Meta-analysis of Clinical Trial Studies.
Indian J Surg Oncol. 2022 Apr 25, 2022;13(2):329-342
. doi: 10.1007/s13193-022-01533-7. PMID: 35782798. Review and Meta-analysis˰




Bernstock JD, Gary SE, Klinger N, Valdes PA, Ibn Essayed W, Olsen HE, Chagoya G, Elsayed G, Yamashita D, Schuss P, Gessler FA, Paolo Peruzzi P, Bag AK, Friedman GK.
Standard clinical approaches and emerging modalities for glioblastoma imaging.
Neurooncol Adv. 2022 May 26;4(1):vdac080
. doi: 10.1093/noajnl/vdac080. PMID: 35821676. Review.




Waqar M, Roncaroli F, Lehrer EJ, Palmer JD, Villanueva-Meyer J, Braunstein S, Hall E, Aznar M, De Witt Hamer PC, D'Urso PI, Trifiletti D, Quiñones-Hinojosa A, Wesseling P, Bors GR.
Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis.
Neurooncol Adv. 2022 Jun 4;4(1):vdac075
. doi: 10.1093/noajnl/vdac075. PMID: 35769410. Review and Meta-analysis.




Singer L, Kumthekar P.
Editorial commentary: Society for Neuro-Oncology 2021 Annual Meeting updates on primary central nervous system tumors.
Chin Clin Oncol. 2022 Jun [7];11(3):18
. doi: 10.21037/cco-22-2. PMID: 35818853. Editorial overview.




Ricciardi L, Manini I, Cesselli D, Trungu S, Piazza A, Mangraviti A, Miscusi M, Raco A, Ius T.
Carmustine Wafers Implantation in Patients With Newly Diagnosed High Grade Glioma: Is It Still an Option?
Front Neurol. 2022 Jun 23;13:884158
. doi: 10.3389/fneur.2022.884158. PMID: 35812101. Review and Meta-analysis.




Du X, He Y, Lin W.
Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for
Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
Front Neurol. 2022 Jun 24;13:882334
. doi: 10.3389/fneur.2022.882334. PMID: 35812103. Review and Meta-analysis.




Evans M, Gill R, Bull KS.
Does a Bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review.
Neurooncol Adv. 2022 Jun 24;4(1):vdac100
. doi: 10.1093/noajnl/vdac100. PMID: 35821674. Review.




Sener U, Ruff MW, Campian JL.
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives.
Int J Mol Sci. 2022 Jun 24;23(13):7046
. doi: 10.3390/ijms23137046. PMID: 35806051. Review.




Galijasevic M, Steiger R, Mangesius S, Mangesius J, Kerschbaumer J, Freyschlag CF, Gruber N, Janjic T, Gizewski ER, Grams AE.
Magnetic Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas: State-of-the-Art.
Cancers (Basel). 2022 Jun 29;14(13):3197
. doi: 10.3390/cancers14133197. PMID: 35804969. Review.




Rodríguez-Camacho A, Flores-Vázquez JG, Moscardini-Martelli J, Torres-Ríos JA, Olmos-Guzmán A, Ortiz-Arce CS, Cid-Sánchez DR, Pérez SR, Macías-González MDS, Hernández-Sánchez LC, Heredia-Gutiérrez JC, Contreras-Palafox GA, Suárez-Campos JJE, Celis-López MÁ, Gutiérrez-Aceves GA, Moreno-Jiménez S.
Glioblastoma Treatment: State-of-the-Art and Future Perspectives.
Int J Mol Sci. 2022 Jun 29;23(13):7207
. doi: 10.3390/ijms23137207. PMID: 35806212. Review.




Al Sharie S, Talafha M, Abu Laban D, Al Awabdeh T, Al-Mousa A, Al-Masri N, Al-Hussaini M.
H3 K27M-mutant diffuse midline glioma with osseous metastases: A case report and a literature review.
Clin Neuropathol. 2022 Jun 30
. doi: 10.5414/NP301475. PMID: 35770519. Case report and Review˰




Cruz JVR, Batista C, Afonso BH, Alexandre-Moreira MS, Dubois LG, Pontes B, Moura Neto V, Mendes FA.
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide.
Cancers (Basel). 2022 Jun 30;14(13):3203
. doi: 10.3390/cancers14133203. PMID: 35804976. Review.




Giustozzi M, Proietti G, Becattini C, Roila F, Agnelli G, Mandalà M.
ICH in patients with primary or metastatic brain cancer treated or not with anticoagulants: a systematic review and meta-analysis.
Blood Adv. 2022 Jun 30:bloodadvances.2022008086
. doi: 10.1182/bloodadvances.2022008086. PMID: 35772127. Review and Meta-analysis.




Prajapati HP, Ansari A.
Updates in the Management of Recurrent Glioblastoma Multiforme.
J Neurol Surg A Cent Eur Neurosurg. 2022 Jun 30
. doi: 10.1055/s-0042-1749351. PMID: 35772723. Review˰




Thakur A, Faujdar C, Sharma R, Sharma S, Malik B, Nepali K, Liou JP.
Glioblastoma: Current Status, Emerging Targets, and Recent Advances.
J Med Chem. 2022 Jul 5, 2020;65(13):8596-8685
. doi: 10.1021/acs.jmedchem.1c01946. PMID: 35786935. Review˰




Diaz M, Schiff D.
Vascular complications in patients with brain tumors.
Curr Opin Oncol. 2022 Jul 6
. doi: 10.1097/CCO.0000000000000875. PMID: 35788556. Review˰




Kurokawa R, Kurokawa M, Baba A, Ota Y, Pinarbasi E, Camelo-Piragua S, Capizzano AA, Liao E, Srinivasan A, Moritani T.
Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors.
Radiographics. 2022 Jul 8:210236
. doi: 10.1148/rg.210236. PMID: 35802502. Review˰